APA (7th ed.) Citation

Vis, D. J., Palit, S. A. L., Corradi, M., Cuppen, E., Mehra, N., Lolkema, M. P., . . . Bergman, A. M. (2025). Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications. Genome Medicine, 17(1), 1. https://doi.org/10.1186/s13073-025-01445-5

Chicago Style (17th ed.) Citation

Vis, Daniel J., et al. "Whole Genome Sequencing of 378 Prostate Cancer Metastases Reveals Tissue Selectivity for Mismatch Deficiency with Potential Therapeutic Implications." Genome Medicine 17, no. 1 (2025): 1. https://doi.org/10.1186/s13073-025-01445-5.

MLA (9th ed.) Citation

Vis, Daniel J., et al. "Whole Genome Sequencing of 378 Prostate Cancer Metastases Reveals Tissue Selectivity for Mismatch Deficiency with Potential Therapeutic Implications." Genome Medicine, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13073-025-01445-5.